Three Case Western Reserve University faculty members recently received significant funding from the National Center for Accelerated Innovation (NCAI) to conduct projects and develop novel technologies targeting sickle cell anemia, malaria, and cystic fibrosis (CF). NCAI supports new technologies and innovative products that have been targeted as…
News
Researchers at Stanford University School of Medicine developed a highly sensitive, specific, rapid and cost-effective assay for cystic fibrosis (CF) screening in newborn babies. The research article detailing the development and performance of the new assay, “Next-Generation Molecular Testing of Newborn Dried Blood Spots for Cystic Fibrosis,” was…
University of Iowa researchers appear to have discovered the long-awaited answer as to why mice that carry cystic fibrosis (CF) mutations do not develop the serious lung disease observed in human CF patients. Their work also revealed a new therapeutic target that might stop CF progression. The study, “Airway acidification initiates host defense abnormalities…
A recent study reported that the presence of transient Group A streptococcus (GAS) in patients with cystic fibrosis (CF) increases the risk of pulmonary exacerbations. The study, “Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis,” was published in the journal…
Parents of a child born with a severe genetic condition such as cystic fibrosis (CF) are greatly affected by their child’s illness and likely to favor early prenatal testing of future pregnancies, researchers at Plymouth University, U.K., report. Their study, “Impact of fetal or child loss on parents’ perceptions of non-invasive prenatal diagnosis for…
CysticLife.org, the largest patient-led social network for the cystic fibrosis (CF) community with more than 8,600 members, has partnered with researchers at the Mayo Clinic to conduct what it says will be the world’s largest CF exercise study. A report by rare disease information…
The Geisel School of Medicine at Dartmouth announced that it has received a $10 million gift from an anonymous donor, plus a $5 million matching donation, also given anonymously, that will be used to accelerate its research into better treatments and, ultimately, a cure for cystic fibrosis (CF). The $15 million in…
A philanthropic donation to Emory University will contribute to the research of new therapies for cystic fibrosis (CF) at the laboratory of Dr. Eric J. Sorscher, a scientific leader in cystic fibrosis research. Sorscher heads a research program at Emory and Children’s Healthcare in Atlanta that focuses on discovering…
The Mayo University Hospital in Ireland has a new €1.4 million day care center for young cystic fibrosis (CF) patients, a much-needed addition in a country with the highest incidence and highest carrier rate of CF in the world. The center, which opened on Jan. 15, 2016, was developed through collaboration between…
The drug ivacaftor appears to be safe for children 2 to 5 years old with specific types of a cystic fibrosis (CF) genetic mutation, according to recent U.K. research. The findings support the drug’s U.S. approval for youngsters in this age group, and also indicate a potential period in early life when organ…
Your CF Community
Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.